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ABSTRACT
Objective: To verify the influence of quality of life in treatment adherence of patients 
with diabetes mellitus. Method: Systematic review of the literature using the databases 
MEDLINE, CINAHL, Scopus, LILACS, SciELO and Web of Science with studies 
published between 2003 and 2014 in English, Portuguese or Spanish. Results: Six 
studies were included in the review, three were identified as having better quality of 
life scores, being related to better adherence to diabetes treatment measured by glycated 
hemoglobin or characteristics related to diet, exercise, use of medication and foot care. 
No association was found between quality of life and adherence in two investigations and 
a study found a negative association between these variables. Conclusion: There is causal 
relationship between quality of life and adherence with diabetes treatment. It is suggested 
that psychosocial aspects of patients should be considered by health professionals in the 
search for better clinical outcomes in diabetes care.
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INTRODUCTION
Diabetes Mellitus (DM) is a public health problem due to 
its increased incidence and prevalence(1). Being a chronic dis-
ease that requires long-term monitoring and individual care 
to prevent complications, DM is associated with high eco-
nomic and social costs to individuals, families and society(1).
According to the World Health Organization (WHO), 
approximately 347 million people worldwide have diabe-
tes, and 80% of deaths from this disease occur in low – or 
middle-income countries like Brazil(2).
Studies show that quality of life (QOL) of patients 
with DM can influence treatment adherence, satisfacto-
rily improving clinical outcomes and reducing the mor-
bidity and mortality rates and disease progression(3-6). 
The literature suggests that the physical and emotional 
conditions under which the individual with DM is in-
serted emerge as important factors in determining their 
behavior related to treatment adherence(7). As an example, 
it can be said that excessive increase of stress in individu-
als with DM, as well as interpersonal and environmental 
factors, negatively interfere with their behavior related to 
treatment adherence(7).
The evaluation of the patient’s QOL is recognized as an 
important area of scientific knowledge, since the concept of 
QOL relates to the notion of health: satisfaction and well-
being in the physical, psychological, socio-economic and 
cultural spheres(8). According to the WHO, QOL can be 
defined as individuals perception of their position in life in the 
context of the culture and value systems in which they live in and 
in relation to their goals, expectations, standards and concerns(9).
Because of the complexity involved in DM, factors re-
lated to the patient, such as emotional aspects and life his-
tory need to be taken into account in serving this group, 
since they are essential to the treatment and prevention of 
chronic complications that the disease can generate(10).
The analysis of the relationship between QOL and 
treatment adherence is still contradictory in the literature. 
Some studies(11-13) show that the best QOL of patients with 
DM is associated with better treatment adherence of the 
disease; however, another research has not found this asso-
ciation(14). Given this context of uncertainty and assuming 
that QOL may influence treatment adherence of individu-
als with DM, we propose this study, which aims to find the 
evidence about the influence of QOL in treatment adher-
ence of patients with DM.
METHOD
This is a systematic review of the literature, defined 
as a form of research that uses as data, the literature on a 
particular topic. This type of research should be developed 
through the application of systematic search methods, criti-
cal appraisal and synthesis of the included information(15).
The search was conducted between the months of Sep-
tember to December 2014 in the databases: Latin American 
databases and Caribbean Health Sciences (LILACS), Medi-
cal Literature Analysis and Retrieval System online (MED-
LINE), Cumulative Index to Nursing and Allied Health Lit-
erature (CINAHL), SCOPUS, Scientific Electronic Library 
Online (SciELO) and Thomson Reuters Web of Science.
The guiding question of this review is: Does the quality 
of life of individuals with DM influence treatment adherence of 
the disease?. We used the PICO strategy for the construction 
of the research question, which is an acronym for Patient, 
Intervention, Comparison and Outcomes. These four com-
ponents are the key elements of the research question for 
the search of evidence in the databases(16). The C element 
of PICO was not used since the objective of this review did 
not include the comparison of different interventions.
The descriptors used in the search were selected from 
the Health Sciences Descriptors (DeCS), Medical Subject 
Headings (MeSH) and titles CINAHL. According to the 
PICO strategy, the following components were considered: 
diabetes, diabetes mellitus, type 1; diabetes mellitus, type 2 (to 
the patient); quality of life and lifestyle (for intervention); pa-
tient compliance and adherence to medication (for outcome).
The descriptors and titles CINAHL were combined with 
the boolean operators “OR” and “AND”. Since the databases 
have different characteristics and specificities, the search was 
performed using different strategies, as described in Chart 1.
Chart 1 – Search strategies for databases – São Paulo, SP, Brazil, 
2015.
Databases Search strategies
LILACS
(tw:(diabetes mellitus)) OR (tw:(diabetes mellitus tipo 1)) 
OR (tw:(diabetes mellitus tipo 2)) AND (tw:(qualidade 
de vida)) AND (tw:(cooperação do paciente)) OR 
(tw:(adesão a medicação))
MEDLINE
(via 
PubMed)
(((("diabetes mellitus, type 2"[MeSH Terms] OR "type 2 
diabetes mellitus"[All Fields] OR "diabetes mellitus, type 
2"[All Fields]) OR ("diabetes mellitus, type 1"[MeSH 
Terms] OR "type 1 diabetes mellitus"[All Fields] OR 
"diabetes mellitus, type 1"[All Fields])) OR ("diabetes 
mellitus"[MeSH Terms] OR ("diabetes"[All Fields] 
AND "mellitus"[All Fields]) OR "diabetes mellitus"[All 
Fields])) AND (("life style"[MeSH Terms] OR ("life"[All 
Fields] AND "style"[All Fields]) OR "life style"[All Fields] 
OR "lifestyle"[All Fields]) OR ("quality of life"[MeSH 
Terms] OR ("quality"[All Fields] AND "life"[All Fields]) 
OR "quality of life"[All Fields]))) AND (("patient 
compliance"[MeSH Terms] OR ("patient"[All Fields] AND 
"compliance"[All Fields]) OR "patient compliance"[All 
Fields]) OR ("medication adherence"[MeSH Terms] OR 
("medication"[All Fields] AND "adherence"[All Fields]) 
OR "medication adherence"[All Fields]))
CINAHL
(MH "Diabetes Mellitus") OR (MH "Diabetes Mellitus, 
Type 2") OR (MH "Diabetes Mellitus, Type 1" AND (MH 
"Quality of Life") AND (MH "Patient Compliance") OR 
(MH "Medication Compliance")
SCOPUS
(TITLE-ABS-KEY (diabetes mellitus) OR TITLE-ABS-KEY 
(diabetes mellitus,type 1) OR TITLE-ABS-KEY (diabetes 
mellitus,type 2) AND TITLE-ABS-KEY (quality of life) 
AND TITLE-ABS-KEY (patient compliance) OR TITLE-
ABS-KEY (medication adherence))
SciELO
(diabetes mellitus) OR (diabetes mellitus type 1) OR 
(diabetes mellitus type 2) AND (quality of life) AND 
(patient compliance) OR (medication adherence)
Web of 
Science
(("diabetes mellitus" OR "diabetes mellitus type 1" OR 
"diabetes mellitus type 2") AND quality of life AND 
("patient compliance" OR "medication adherence"))
Primary and secondary studies available in full, pub-
lished in national and international journals between 2003 
and 2014 in English, Spanish or Portuguese languages and 
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that addressed the association between QOL of adult pa-
tients (over 18 years) with DM (type 1 and/or 2) and treat-
ment adherence of disease were included.
Book chapters, editorials, case series, comments, theses 
and dissertations and studies that addressed gestational dia-
betes or pre-diabetes were excluded from the sample.
The selection of studies was made through the assess-
ment of the titles, followed by reading of the abstracts and 
then evaluation of studies in full. For extracting data from 
the studies, we developed two instruments. The first con-
tained the following information: title, author, objectives, 
study type, publication year and country. The second ad-
dressed the DM type, population, group most affected by 
gender, QOL assessment instrument, adherence assessment 
and relationship between QOL treatment adherence.
The quality assessment of studies design was performed 
independently by two reviewers using the instrument ap-
plication Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE), a checklist contain-
ing 22 items with recommendations about what should be 
included in a more precise and full description of observa-
tional studies(17). This analysis was only descriptive, that is, 
not aimed at the exclusion of the sample studies.
The data are presented in figures and Boxes and the re-
sults in a descriptive way, they are also compared and evalu-
ated for their applicability.
RESULTS
From the searches in the databases and using the eligi-
bility criteria, six studies were included in the final sample. 
Figure 1 shows the study selection process.
1507 potential studies found 
in the databases
Studies excluded 
by titles
(n=1149)
ID
EN
TI
FI
C
A
TI
O
N
SC
R
EE
N
IN
G
EL
IG
IB
IL
IT
Y
IN
C
LU
D
ED
Duplicated
(n=1)
Studies included 
according to 
abstracts
(n=357)
Excluded based on 
the abstracts
(n=330)
Full-text reading
(n=27)
Excluded studies after full-
text reading (n=21)
-17 did not evaluate the 
influenceQOL in 
adherence
-1 letter to the editor
-2 editorials
-1 case report
Studies included
(n=6)
Figure 1 – Flowchart of study selection process, Sao Paulo, SP, 
Brazil, 2015
As the method used, 1507 potential studies were identi-
fied from the search strategies, and the Medline database 
showed the majority of studies (53.0%), followed by LI-
LACS (18.7%), CINAHL (9.6%), SCOPUS (9.0%), Sci-
ELO (5.0%) and Web of Science (4.7%).
Of the six studies that composed the final sample, five 
(83,3%)(18-22) were found in MEDLINE and one (16,7%)(23) 
in CINAHL.
It is observed in Chart 2 that no study had agreement 
with all items in the STROBE. However, all the items that 
composed the final sample of this review have attended at 
least 50% of the items of the STROBE and the agreement 
among reviewers ranged from 13 to 20 (59.1 to 90.9%) of 
the checklist items.
Two studies(19,21) were performed in the United States, 
one in Thailand(18), one in Singapure(23), one in Mexico(22) 
and another one in Netherlands(20). The surveys were con-
ducted between 1998 and 2009 and published from 2004 to 
2012. English was the language found in all investigations, 
as well as the observational study design.
Chart 3 shows that the sample/population ranged from 
111 to 1149 individuals, and the female gender was pre-
dominant in the studies. Considering the total of 2060 pa-
tients analyzed, it can be said that the majority (56.8%) 
were women. The type 2 DM was investigated in all studies 
and only two studies also included patients with type 1 DM 
in their analysis. The age of participants ranged from 21 to 
97 years and the mean 44.7 to 68.7 years.
Note in Chart 4 that QOL was measured by different 
instruments: the generics, like The 36-Item Short Form 
Health Survey (SF-36), the 12-Item Short-Form Health 
Survey (SF-12), World Health Organization Quality of 
Life instrument (WHOQOL-100), The World Health 
Organization’s WHOQOL-BREF quality of life assess-
ment (WHOQOL – bref ) and 5-D EuroQol (EQ-5D), 
and the specific ones as the Audit of Diabetes-dependent 
quality of Life (ADDQoL), used to assess QOL in dia-
betics, and The RAND-36 Measure of Health-Related 
Quality of Life (Rand-36), which evaluates health-related 
quality of life.
The test of glycated hemoglobin (A1c) was used ex-
clusively as adherence measure in three studies(20-21,23). One 
study(22) analyzed the tablet counts associated with the 
knowledge of the disease. Another study(18) used the dietary 
control with exercise, use of medication and foot care as ad-
herence measures for the treatment of diabetes. Guidelines 
from American Diabetes Association of 2005 suggest the 
analysis of treatment adherence of participants: two tests for 
A1c, a test for cholesterol, one microalbuminuria test and 
an eye examination in one year period(19).
The relationship between QOL and treatment adher-
ence of patients with DM was found in four (66.7%) stud-
ies(18-19,21,23). Two studies (33,3%)(20,22) found no association 
between these variables.
The USA studies have shown different results: a research 
that analyzed 111 diabetics type 1 or 2 identified that pa-
tients with lower scores in the mental health domain of the 
SF-12 did better in controlling diabetes(19). Another study 
showed, in a population of 1,116 patients, the 1% increase 
in the scores of the mental health domain of the SF-36 was 
related to the 5% decrease of the A1c values(21).
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Chart 3 – Distribution of studies according to the type of DM investigated, population size/sample, gender and mean age – São Paulo, 
SP, Brazil, 2015.
Study Type of Diabetes Mellitus Population/sample Gender Mean age (SD)
S1 DM 2 282 Femalen=144 (51.1%) 58.1 ± 8.8
S2 DM 2 238 Femalen=148 (62.2%) 58.7 ± 9.6
S3 DM 2 164 Femalen=129 (78.7%) 48.5 ± 7.9
S4 DM 1DM 2 111
Female
n=95 (85.6%) 44.7 ± 9.67
S5 DM 2 1149 Femalen= 662 (57.6%) 68.7 ± 11.5
S6 DM 1DM 2 1116
Female
n= 561 (50.3%) 56.5*
SD: standard deviation 
* standard deviation not cited in the study
Chart 2 – Distribution of studies by title, objective, study design, year and country – São Paulo, SP, Brazil, 2015.
Study identification and 
number of items STROBE Title Objective Study design
Year, 
country
Study 1 (S1)
STROBE:20 items
Health-related quality of life and gly-
cemic control in patients with Type 2 
diabetes mellitus in Singapore(23)
To investigate the quality of life related 
to health of patients with diabetes 
mellitus in Singapore and its associa-
tion with the DM characteristics and 
glycemic control
Observational, 
cross-sectional
2012, 
Singapure
Study 2 (S2)
STROBE: 19 items
Quality of life associated with treat-
ment adherence in patients with type 
2 diabetes: a cross-sectional study(22)
To evaluate the association between 
QOL and the adherence behavior to 
treatment, knowledge of the prescrip-
tion and the attitude towards treatment 
adherence
Observational, 
cross-sectional 
comparative
2008, 
Mexico
Study 3 (S3)
STROBE:11 items
Quality of life and compliance 
among type 2 diabetic patients(18)
To explore the quality of life of pa-
tients with type 2 DM and relate it to 
compliance with treatment
Observational, 
transversal
2008, 
Thailand
Study 4 (S4)
STROBE: 14 items
Health-related quality of life and 
treatment compliance with diabetes 
care(19)
To explore the relationship between 
quality of life and treatment adherence
Observational, 
longitudinal
2006, 
USA
Study 5 (S5)
STROBE: 19 items
Cross-sectional relationship between 
glycemic control, hyperglycemic 
symptoms and quality of life in type 2 
diabetes (ZODIAC-2)(20)
To describe the relationship between 
glycemic control, hyperglycemic 
symptoms and quality of life in dia-
betic patients
Observational, 
cross-sectional
2005, 
Nether-
lands
Estudo 6 (E6)
STROBE: 20 items
Association between glycaemic 
control and quality of life in diabetes 
mellitus(21)
To assess the association between 
quality of life and change in A1c in 
diabetic patients during a year
Observational, 
cohort
2004, 
USA
USA: The United States of America; A1c: glycated haemoglobin.
Chart 4 – Distribution of studies according to the evaluation of QOL instrument used, treatment adherence measures and influence 
of QOL in adherence – São Paulo, SP, Brazil, 2015.
QOL 
instrument Adherence measure
Influence 
of QOL’s in 
adherence
S1 – EQ-5D– ADDQoL A1c test YES
S2 WHOQOL-100 – Indirect method of tablet count– Knowledge of medical prescription on oral hypoglycemic dosage and frequency NO
S3 WHOQOL-bref – Thai
– A questionnaire containing information on diet control, exercise, medication use
and foot care YES
S4 SF-12 Measured in accordance with guidelines of the American Diabetes Association (2005), which includes two A1c tests, a cholesterol test, a microalbuminuria test and an eye examination YES
S5 Rand-36 A1c test NO
S6 SF-36 A1c test YES
EQ-5D: Euroqol 5-D; ADDQoL: Audit of Diabetes-dependent Quality of Life; WHOQOL: World Health Organization Quality of Life instrument; SF-12: 12-Item 
Short-Form Health Survey; Rand-36: The RAND-36 Measure of Health-Related Quality of Life, SF-36: The 36-Item Short Form Health Survey; A1c: glycated hemoglobin;
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Results of study conducted in Singapore(23) have shown 
that diabetics with lower A1c values had better quality of 
life. Likewise, the research from Thailand(18) identified as-
sociation between good scores for quality of life and treat-
ment adherence. The main factors related to worse QOL 
of diabetics were: low family income, use of insulin, longer 
disease progression and low school level(18-19,22-23).
DISCUSSION
This review aimed to understand the relationship of 
QOL of diabetics with treatment adherence of the disease. 
In the selection of studies, we excluded 1149 references by 
title analysis. After screening 357 abstracts, 330 referenc-
es were excluded, leaving 27 selected studies for full-text 
analysis. After full-text reading, 21 studies were excluded 
because they did not meet the inclusion criteria, therefore, 
six studies were included. Although the amount of stud-
ies initially retrieved was high (1507), the majority (76.2%) 
was excluded from the review after reading the title. This 
result may be due to the interest of the scientific community 
on quality of life and treatment adherence topics, since the 
studies chose these descriptors. However, these studies were 
excluded because they did not investigate the relationship 
between these two variables.
In this review we chose to use only descriptors because 
they use a single language for indexing and retrieval of in-
formation in databases(24-25), allowing recovery of studies 
that narrowly meet the objectives of this review.
Regarding the characterization of the six studies in-
cluded in this review, all were observational(18-23), with a 
predominance of cross-sectional studies(18,20,22-23). In obser-
vational studies, the researcher does not intervene in the 
analyzed group because they would only be analysed in the 
epidemiological method of a natural experiment, noting the 
association between exposure and disease; because of that, 
they are low cost and its performance is fast, with easy ap-
plication in relation to the experimental studies(26).
S3(18) was the one with the lowest compliance (50%) 
with the items in the STROBE, and information concern-
ing the methodology was identified as weakness in the in-
strument checklist application.
The participants of the studies included in this review 
were mostly women (56.8%). This can be explained by the 
fact that women are more frequently diagnosed with the 
disease than men due to their increased demand for health 
services(5,27-28).
Type 2 DM was the most prevalent and the mean age 
of participants ranged from 44.7 to 68.7 years. This finding 
is supported by the profile of the disease. It is known that 
about 90% of the diabetics are type 2, and that it affects 
mainly people over the age of 40 years(5,29-30).
Different instruments were used to measure QOL, in 
general, they had physical (independence, ability to per-
form daily tasks, pain, vitality, well-being), psychological 
(emotional, mental health, anxiety/depression, social (envi-
ronment, social aspects) and spiritual (religious) questions. 
The use of QOL assessment instruments provides real and 
concrete assessment of the overall impact that the disease 
causes in individuals’ lives and its main advantage include 
subjective aspects that are not identified by other evalu-
ation methods(31). The use of generic and specific instru-
ments have advantages and disadvantages in measuring the 
QOL of patients with DM. Specific instruments include 
the symptoms and dysfunctions characteristics of the DM; 
however, they are restricted to these aspects, preventing an 
QOL overview. Also, they do not allow comparison be-
tween diabetic and non-diabetic individuals. In the litera-
ture, there is no consensus about the best instrument to 
assess QOL of diabetics(4).
In this review, there was a relationship between QOL 
and treatment adherence in S1(23), S3(18), S4(19) and S6(21). The 
results of S4(19) and S5(20) showed that the mental health 
domain of the SF-12 and SF-36 instruments were related 
to treatment adherence.
S4(19) found a negative association between mental health 
domain of the SF-12 and treatment adherence of diabetics. 
S6(21) identified a positive association between mental health 
measured by the SF-36 and treatment adherence. Despite 
presenting discordant results, the findings about the psycho-
logical domain with the treatment adherence are in accor-
dance with the results of another study(30) which found that 
diabetics with better scores on the psychological dimension 
of the WHOQOL-Bref kept better glycemic control.
Researchers(32-33) found that the SF-12, even though 
seem as a generic instrument for assessing QOL, demon-
strates a level of sensitivity and high reliability, thus validat-
ing its structure. One hypothesis that could explain this dif-
ference in results between S4(19) and S6(21) is that studies do 
not apply the same version of the instruments and analyze 
sample size and mean age differently: S4(19) used the SF-12 
as a measure of QOL assessment in a sample of 111 par-
ticipants with a mean age 44.7 years. While S6(21) used the 
SF-36 in a population 10 times larger (n=1116) than the 
previous study and with higher mean age of participants: 
approximately 56 years.
The lower A1c was associated with better QOL in S1(23) 
and S6(21). The A1c is an important parameter for glycemic 
control in patients with DM. The A1c is strongly related to 
the onset and progression of chronic complications of DM(34). 
Assuming that diabetic patients with lower levels of A1c have 
better QOL, it can be inferred that individuals in the sample 
of these studies are more adherent to treatment of the disease.
Although A1c is a good glycemic control parameter, 
there are currently other methods to assess adherence to 
the therapeutic regimen, such as the questionnaire for 
treatment adherence, Summary of Diabetes Self-Care 
Activities Questionnaire (SDSCA), and the questionnaire 
Treatment Measure Adherence (TMA). These adherence 
questionnaires are effective in assessing treatment adher-
ence since they are based on self-reporting answers and use 
specific questions that cover major self-care activities of the 
diabetic patient(29,35).
The metabolic control is complex and depends on the 
effective implementation of various actions, such as dietary 
control, physical exercise, proper follow-up of drug treat-
ment, among others. However, this review found only one 
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study (S3)(18) which used such actions as treatment adherence. 
Obtaining a good DM metabolic control prevents the onset 
or slow down the progression of diabetes complications(36).
There was no association between QOL and treatment 
adherence in S2(22) and S5(20). It can be inferred that the use 
of an indirect method to measure treatment adherence, as 
used in S2, may have affected this result. In this sense, it is 
assumed that analyzing only tablet counts and knowledge 
of the patient on medical prescription are not considered 
good parameters for metabolic control.
The negative association between glucose symptoms and 
QOL was the main result found in S5(20). It is difficult to 
explain the absence of the relationship between QOL and 
DM adherence, especially considering the negative rela-
tionship between glycemic symptoms and QOL found in 
the study. Participants in the studies that had higher fre-
quency of blood glucose symptoms such as hyperglycemia, 
had lower QOL levels and higher levels of A1c, but there 
was no association between the deterioration of QOL of 
patients with treatment adherence.
The insulin was the only type of treatment associated 
with worsening of diabetic QOL(23), this is due to the pain 
reported by patients related to the application of the drug. 
Studies(4,37) corroborate this finding as they establish that 
the insulin use resulted in pain and side effects such as lipo-
dystrophy, factors impacting on the individual’s self-esteem, 
thus influencing the psychological and physical aspects.
As limitations of this systematic review, we emphasize 
the language restriction (English, Portuguese and Spanish) 
and the publication period (2003-2014), in addition to the 
exclusive use of descriptors in the databases.
CONCLUSION
The influence of the diabetic patient’s QOL on treat-
ment adherence was identified in four of the six studies in-
cluded. The best QOL was associated with treatment adher-
ence of DM since three studies used different assessment 
instruments (EQ-5D, ADDQoL, WHOQOL-bref-Thai 
and SF-36). An investigation found that the worse QOL, 
according to the mental component of the SF-12, was nega-
tively associated with treatment adherence of the disease.
Health professionals need to pay attention to the di-
mensions of QOL that are most affected in patients with 
DM and intervene early on, since this aspect may play 
negative influence on treatment adherence of the disease.
Through the findings of this review, it is possible to infer 
that studies with larger sample sizes and longer follow-ups 
could generate more relevant clinical findings and more 
clearly elucidate the relationship between quality of life, 
glycemic control and treatment adherence.
RESUMO
Objetivo: Verificar a influência da qualidade de vida na adesão ao tratamento do paciente com diabetes mellitus. Método: Revisão 
sistemática da literatura nas bases de dados MEDLINE, CINAHL, SCOPUS, LILACS, SciELO e Web of Science de estudos 
publicados entre 2003 e 2014 nos idiomas inglês, português ou espanhol. Resultados: Foram incluídos seis estudos na revisão, sendo 
que três identificaram que melhores escores de qualidade de vida estão relacionados com melhor adesão ao tratamento do diabetes 
mensurada pela hemoglobina glicada ou características relacionadas à dieta, a exercícios, ao uso de medicamentos e aos cuidados com os 
pés. Não foi encontrada associação entre qualidade de vida e adesão em duas investigações, e um estudo encontrou associação negativa 
entre essas variáveis. Conclusão: Existe relação causal entre a qualidade de vida e o cumprimento do tratamento do diabetes. Sugere-se 
que aspectos psicossociais dos pacientes devam ser considerados pelos profissionais de saúde na busca por melhores resultados clínicos 
no tratamento do diabetes.
DESCRITORES
Diabetes Mellitus; Qualidade de Vida; Cooperação do Paciente; Adesão à Medicação; Revisão.
RESUMEN
Objetivo: Verificar la influencia de la calidad de vida en la adhesión al tratamiento del paciente con diabetes mellitus. Método: Revisión 
sistemática de la literatura en las bases de datos MEDLINE, CINAHL, SCOPUS, LILACS, SciELO y Web of Science de estudios 
publicados entre 2003 y 2004 en los idiomas inglés, portugués o español. Resultados: Fueron incluidos seis estudios en la revisión, 
siendo que tres identificaron que mejores puntajes de calidad de vida están relacionados con mejor adhesión al tratamiento de la diabetes 
medida por la hemoglobina glicada o características relacionadas con la dieta, ejercicios, uso de fármacos y cuidados con los pies. No fue 
encontrada asociación entre calidad de vida y adhesión en dos investigaciones, y un estudio encontró asociación negativa entre dichas 
variables. Conclusión: Existe relación causal entre la calidad de vida y el cumplimiento del tratamiento de la diabetes. Se sugiere que 
los profesionales sanitarios deben considerar los aspectos psicosociales de los pacientes en la búsqueda por mejores resultados clínicos 
en el tratamiento de la diabetes.
DESCRIPTORES
Diabetes Mellitus; Calidad de Vida; Cooperación del Paciente; Cumplimiento de la Medicación; Revisión.
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